MoneyWorks4Me

Cadila Healthcare informs about press release

14 Mar 2019 Evaluate

Cadila Healthcare has informed about press release dated March 14, 2019 titled ‘Zydus receives tentative approval from the USFDA for Sitagliptin and Metformin Hydrochloride Extended-Release Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..